中村 真樹 なかむら まさき 先生

来歴等

略歴

2001年 東京大学医学部 卒業
2001年 東京大学医学部附属病院 泌尿器科 技官
2001年 焼津市立病院 麻酔科 レジデント
2002年 東京大学医学部附属病院 泌尿器科 助手
2002年 埼玉社会保険病院 泌尿器科
2003年 関東労災病院 泌尿器科
2005年 NTT東日本関東病院 泌尿器科
2007年 東京大学大学院医学系研究科 外科学専攻 入学
2011年 東京大学大学院医学系研究科 外科学専攻 卒業
2011年 スウェーデン カロリンスカ研究所 博士研究員
2017年 東京大学医学部附属病院 助教
2019年 東京大学医学部附属病院 講師
2021年 NTT東日本関東病院 泌尿器科 主任医長
2023年 NTT東日本関東病院 泌尿器科 部長

論文

• 1. TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury.

  Yamanishi Y, Kitaura J, Izawa K, Kaitani A, Komeno Y, Nakamura M, Yamazaki S, Enomoto Y, Oki T, Akiba H, Abe T, Komori T, Morikawa Y, Kiyonari H, Takai T, Okumura K, Kitamura T. J Exp Med. 2010 Jul 5;207(7):1501-11. doi: 10.1084/jem.20090581. Epub 2010 Jun 21.

• 2. Transforming growth factor-β-stimulated clone-22 is a negative-feedback regulator of Ras?/?Raf signaling: Implications for tumorigenesis.

  Nakamura M, Kitaura J, Enomoto Y, Lu Y, Nishimura K, Isobe M, Ozaki K, Komeno Y, Nakahara F, Oki T, Kume H, Homma Y, Kitamura T. Cancer Sci. 2012 Jan;103(1):26-33.

• 3. Association between lower urinary tract symptoms and sexual dysfunction assessed using the core lower urinary tract symptom score and International Index of Erectile Function-5 questionnaires.

  Nakamura M, Fujimura T, Nagata M, Hosoda C, Suzuki M, Fukuhara H, Enomoto Y, Nishimatsu H, Kume H, Igawa Y, Homma Y. Aging Male. 2012 Jun;15(2):111-4.

• 4. Opposing Effects of Circadian Clock Genes Bmal1 and Period2 in Regulation of VEGF-Dependent Angiogenesis in Developing Zebrafish.

  Jensen LD, Cao Z, Nakamura M, Yang Y, Br?utigam L, Andersson P, Zhang Y, Wahlberg E, L?nne T, Hosaka K, Cao Y. Cell Rep. 2012 Aug 30;2(2):231-41. Epub 2012 Aug 9.

• 5. Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodeling and metastasis.

  Hosaka K, Yang Y, Seki T, Nakamura M, Andersson P, Rouhi P, Yang X, Jensen L, Lim S, Feng N, Xue Y, Li X, Larsson O, Ohhashi T, Cao Y. Nat Commun. 2013;4:2129. doi: 10.1038/ncomms3129.

• 6. Novel mechanism of macrophage-mediated metastasis revealed in a zebrafish model of tumor development.

  Wang J, Cao Z, Zhang XM, Nakamura M, Sun M, Hartman J, Harris RA, Sun Y, Cao Y. Cancer Res. 2015 Jan 15;75(2):306-15. doi: 10.1158/0008-5472. CAN-14-2819. Epub 2014 Dec 9.PMID: 25492861

• 7. VEGF-B-Neuropilin-1 signaling is spatiotemporally indispensable for vascular and neuronal development in zebrafish.

  Jensen LD, Nakamura M, Br?utigam L, Li X, Liu Y, Samani NJ, Cao Y. PNAS. 2015 Oct 19.pii: 201510245.

• 8. The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages.

  Yang Y, Andersson P, Hosaka K, Zhang Y, Cao R, Iwamoto H, Yang X, Nakamura M, Wang J, Zhuang R, Morikawa H, Xue Y, Braun H, Beyaert R, Samani N, Nakae S, Hams E, Dissing S, Fallon PG, Langer R, Cao Y. Nat Commun. 2016 May 6;7:11385.

• 9. Co-option of pre-existing vascular beds in adipose tissue controls tumor growth rates and angiogenesis.

  Lim S, Hosaka K, Nakamura M, Cao Y. Oncotarget. 2016 Jun 21;7(25):38282-38291.

• 10. Endothelial PDGF-CC regulates angiogenesis-dependent thermogenesis in beige fat.

  Seki T, Hosaka K, Lim S, Fischer C, Honek J, Yang Y, Andersson P, Nakamura M, N?slund E, Yl?-Herttuala S, Sun M, Iwamoto H, Li X, Liu Y, Samani NJ, Cao Y. Nat Commun. 2016 Aug 5;7:12152.

• 11. Discontinuation of anti-VEGF cancer therapy promotes metastasis through a liver revascularization mechanism.

  Yang Y, Zhang Y, Iwamoto H, Hosaka K, Seki T, Andersson P, Lim S, Fischer C, Nakamura M, Abe M, Cao R, Skov PV, Chen F, Chen X, Lu Y, Nie G, Cao Y. Nat Commun. 2016 Sep 1;7:12680

• 12. Off-tumor targets compromise antiangiogenic drug sensitivity by inducing kidney erythropoietin production.

  Nakamura M, Zhang Y, Yang Y, Sonmez C, Zheng W, Huang G, Seki T, Iwamoto H, Ding B, Yin L, Foukakis T, Hatschek T, Li X, Hosaka K, Li J, Yu G, Wang X, Liu Y, and Cao Y. PNAS 2017 ; published ahead of print Oct. 23

• 13. A miR-327?FGF10?FGFR2-mediated autocrine signaling mechanism controls white fat browning.

  Fischer C, Seki T, Lim S, Nakamura M, Andersson P, Yang Y, Honek J, Wang Y, Gao Y, Chen F, Samani NJ, Zhang J, Miyake M, Oyadomari S, Yasue A, Li X, Zhang Y, Liu Y, Cao Y. Nat Commun. 2017; 8: 2079. Published online 2017 Dec 12. doi: 10.1038/s41467-017-02158-z

• 14. Dual roles of endothelial FGF-2-FGFR1-PDGF-BB and perivascular FGF-2-FGFR2- PDGFRβ signaling pathways in tumor vascular remodeling.

  Hosaka K, Yang Y, Nakamura M, Andersson P, Yang X, Zhang Y, Seki T, Scherzer M, Dubey O, Wang X, Cao Y. Cell Discov. 2018 Jan 16;4:3. doi: 10.1038/s41421-017-0002-1. eCollection 2018.

• 15. Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance.

  Iwamoto H, Abe M, Yang Y, Cui D, Seki T, Nakamura M, Hosaka K, Lim S, Wu J, He X, Sun X, Lu Y, Zhou Q, Shi W, Torimura T, Nie G, Li Q, Cao Y. Cell Metab. 2018 Jul 3;28(1):104-117.e5. doi:10.1016/j.cmet.2018.05.005. Epub 2018 May 31.

• 16. Aggressive Cancer Behavior of Latent Gleason Pattern 5 in Prostatectomy Specimens.

  Fujimura T, Fukuhara H, Yamada Y, Taguchi S, Sugihara T, Niimi A, Nakamura M, Nakagawa T, Igawa Y, Homma Y, Kume H. Anticancer Res. 2018 Nov;38(11):6529-6535. doi: 10.21873/anticanres.13018.

• 17. Immune-related adverse events predict the therapeutic efficacy of pembrolizumab in urothelial cancer patients.

  Kawai T, Sato Y, Makino K, Yamada Y, Nomiya A, Nakamura M, Yamada D, Suzuki M, Igawa Y, Kume H. Eur J Cancer. 2019 Jul;116:114-115. doi: 10.1016/j.ejca.2019.05.017. Epub 2019 Jun 10. PMID: 31195355

• 18. Comprehensive epigenome characterization reveals diverse transcriptional regulation across human vascular endothelial cells.

  Nakato R, Wada Y, Nakaki R, Nagae G, Katou Y, Tsutsumi S, Nakajima N, Fukuhara H, Iguchi A, Kohro T, Kanki Y, Saito Y, Kobayashi M, Izumi-Taguchi A, Osato N, Tatsuno K, Kamio A, Hayashi-Takanaka Y, Wada H, Ohta S, Aikawa M, Nakajima H, Nakamura M, McGee RC, Heppner KW, Kawakatsu T, Genno M, Yanase H, Kume H, Senbonmatsu T, Homma Y, Nishimura S, Mitsuyama T, Aburatani H, Kimura H, Shirahige K. Epigenetics Chromatin. 2019 Dec 19;12(1):77. doi: 10.1186/s13072-019-0319-0. PMID: 31856914

• 19. Inverted papilloma of the urinary bladder shows fluorescence on photodynamic diagnosis using 5-aminolevulinic acid.

  Oshina T, Kawai T, Sato Y, Miyakawa J, Miyama Y, Makino K, Akiyama Y, Yamada Y, Nakamura M, Yamada D, Suzuki M, Ushiku T, Kume H. Photodiagnosis Photodyn Ther. 2020 Jun;30:101766. doi: 10.1016/j.pdpdt.2020.101766. Epub 2020 Apr 18. PMID: 32311542

• 20. Comparison of perioperative outcomes in elderly (age ≧ 75 years) vs. younger men undergoing robot-assisted radical prostatectomy.MID: 32497131

  Yamada Y, Teshima T, Fujimura T, Sato Y, Nakamura M, Niimi A, Kimura N, Kakutani S, Kawai T, Yamada D, Suzuki M, Kume H. PLoS One. 2020 Jun 4;15(6):e0234113. doi: 10.1371/journal.pone.0234113. eCollection 2020.P

• 21. Therapeutic paradigm of dual targeting VEGF and PDGF for effectively treating FGF-2 off-target tumors.

  Hosaka K, Yang Y, Seki T, Du Q, Jing X, He X, Wu J, Zhang Y, Morikawa H, Nakamura M, Scherzer M, Sun X, Xu Y, Cheng T, Li X, Liu X, Li Q, Liu Y, Hong A, Chen Y, Cao Y. Nat Commun. 2020 Jul 24;11(1):3704. doi: 10.1038/s41467-020-17525-6. PMID: 32709869

• 22. The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study.

  Tohi Y, Kato T, Matsumoto R, Shinohara N, Shiga K, Yokomizo A, Nakamura M, Kume H, Mitsuzuka K, Sasaki H, Egawa S, Matsumura M, Hashine K, Inokuchi J, Eto M, Baba H, Ichikawa T, Kinoshita H, Matsuda T, Kakehi Y, Sugimoto M.　Int J Clin Oncol. 2020 Dec;25(12):2107-2114. doi: 10.1007/s10147-020-01761-3. Epub 2020 Aug 8.　PMID: 32770439

• 23. A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma.

  Matsui H, Kawai T, Sato Y, Ishida J, Kadowaki H, Akiyama Y, Yamada Y, Nakamura M, Yamada D, Akazawa H, Suzuki M, Komuro I, Kume H. Int Heart J. 2020 Sep 29;61(5):1070-1074. doi: 10.1536/ihj.20-162. Epub 2020 Sep 12. PMID: 32921673.

• 24. Latent prostate cancer among Japanese males: a bibliometric study of autopsy reports from 1980-2016.

  Takeshima Y, Suzuki M, Miyakawa J, Tsuru I, Yamada Y, Nakamura M, Sato Y, Kawai T, Yamada D, Morikawa T, Kume H. Jpn J Clin Oncol. 2021 Jan 1;51(1):156-159. doi: 10.1093/jjco/hyaa161. PMID: 32875336

• 25. Dermatomyositis associated with prostate adenocarcinoma with neuroendocrine differentiation.

  Minagawa H, Kawai T, Matsumoto A, Makino K, Sato Y, Nagasaka K, Tokura M, Tanaka N, Ito E, Yamada Y, Nakamura M, Yamada D, Suzuki M, Murata T, Kume H. BMC Urol. 2021 Jan 7;21(1):8. doi: 10.1186/s12894-020-00779-z. PMID: 33413292

• 26. Impact of age, body mass index, and renal function for severe hypotension caused by oral 5-aminolevulinic acid administration in patients undergoing transurethral resection of bladder tumor.

  Miyakawa J, Kawai T, Makino K, Akiyama Y, Yamada Y, Nakamura M, Sato Y, Yamada D, Suzuki M, Kume H. Photodiagnosis Photodyn Ther. 2021 Mar;33:102179. doi: 10.1016/j.pdpdt.2021.102179. Epub 2021 Jan 8.

• 27. Relationship between the frequency of electrocautery of Hunner lesions and changes in bladder capacity in patients with Hunner type interstitial cystitis.

  Akiyama Y, Zaitsu M, Watanabe D, Yoshimura I, Niimi A, Nomiya A, Yamada Y, Sato Y, Nakamura M, Kawai T, Yamada D, Suzuki M, Kume H, Homma Y. Sci Rep. 2021 Jan 8;11(1):105. doi: 10.1038/s41598-020-80589-3. PMID: 33420263

• 28. Clinical characterization of interstitial cystitis/bladder pain syndrome in women based on the presence or absence of Hunner lesions and glomerulations.

  Watanabe D, Akiyama Y, Niimi A, Nomiya A, Yamada Y, Sato Y, Nakamura M, Kawai T, Yamada D, Suzuki M, Igawa Y, Kume H, Homma Y. Low Urin Tract Symptoms. 2021 Jan;13(1):139-143. doi: 10.1111/luts.12344. Epub 2020 Aug 23. PMID: 32830459

• 29. Impact of Initial Computed Tomography Findings on Management of Atypical Urinary Cytology of the Upper Urinary Tract.

  Takemura K, Kawai T, Sato Y, Miyakawa J, Taguchi S, Akiyama Y, Yamada Y, Nakamura M, Yamada D, Suzuki M, Nakagawa T, Kume H. Urol Int. 2021;105(7-8):619-623. doi: 10.1159/000512978. Epub 2021 Jan 28. PMID: 33508829

• 30. Novel operative technique of advancement urethral meatoplasty utilizing buccal mucosa for Vulvar Paget's disease with urethral invasion: two case reports.

  Nakamura M, Hakozaki Y, Iwata S, Sato Y, Makino K, Kawai T, Yamada Y, Yamada D, Suzuki M, Omatsu J, Abe M, Hoshi K, Kume H, Igawa Y. J Med Case Rep. 2021 Mar 28;15(1):136. doi: 10.1186/s13256-021-02729-1.

• 31. Granulomatous prostatitis with high suspicion of prostatic adenocarcinoma on radiological imaging.

  Ambe Y, Nakamura M (Corresponding author), Shirakawa N, Inatsu H, Amakawa R, Inoue Y, Yoshimatsu T, Miura S, Morikawa T, Kusakabe M, Shiga Y. IJU Case Rep. 2021 May 6;4(4):247-249. doi: 10.1002/iju5.12300. eCollection 2021 Jul. PMID: 34258540

• 32. Assessment of surgical outcomes of off-clamp open partial nephrectomy without renorrhaphy for ?T1b renal tumours.

  Nakamura M, Ambe Y, Teshima T, Shirakawa N, Inatsu H, Amakawa R, Inoue Y, Yoshimatsu T, Imai S, Kusakabe M, Morikawa T, Kameyama S, Shiga Y. Int J Clin Oncol. 2021 Jun 16. doi: 10.1007/s10147-021-01966-0. PMID: 34136964

• 33. Immune-related dermatitis during combined treatment with pembrolizumab and axitinib in a patient with metastatic renal cell\x92carcinoma with stasis dermatitis.

  Imai S, Nakamura M (Corresponding author), Chujo S, Ooki R, Inoue Y, Horiuchi H, Morikawa T, Uchino K, Igarashi A, Shiga Y. IJU Case Rep. 2021 Aug 5;4(6):386-390. doi: 10.1002/iju5.12356. eCollection 2021 Nov. PMID: 34755064

• 34. Early recurrence of bladder cancer in the colon after robot-assisted radical cystectomy: Disappearance following dose-dense methotrexate, vinblastine, doxorubicin and cisplatin treatment.

  Noda M, Nakamura M (Corresponding author), Kawai T, Sato Y, Yamada Y, Akiyama Y, Yamada D, Suzuki M, Kume H. IJU Case Rep. 2021 Sep 8;4(6):429-432. doi: 10.1002/iju5.12370. eCollection 2021 Nov. PMID: 34755076

• 35. Micropetrosis in hemodialysis patients.

  Yajima A, Tsuchiya K, Burr DB, Murata T, Nakamura M, Inaba M, Tominaga Y, Tanizawa T, Nakayama T, Ito A, Nitta K. Bone Rep. 2021 Nov 27;15:101150. doi: 10.1016/j.bonr.2021.101150. eCollection 2021 Dec. PMID: 3492672

• 36. Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study.

  Int J Clin Oncol. Tohi Y, Kato T, Nakamura M, Matsumoto R, Sasaki H, Mitsuzuka K, Inokuchi J, Hashine K, Yokomizo A, Naito H, Hara I, Kawamura N, Inoue M, Fukuhara H, Maruyama S, Sakamoto S, Saito T, Egawa S, Kakehi Y, Sugimoto M. Int J Clin Oncol. 2022 Jan;27(1):194-201. doi: 10.1007/s10147-021-02041-4. Epub 2021 Oct 2. PMID: 34599725.

• 37. Impact of health-related quality of life on repeat protocol biopsy compliance on active surveillance for favorable prostate cancer: results from a prospective cohort in the PRIAS-JAPAN study.

  Tohi Y, Kato T, Yokomizo A, Mitsuzuka K, Tomida R, Inokuchi J, Matsumoto R, Saito T, Sasaki H, Inoue K, Kinoshita H, Fukuhara H, Maruyama S, Sakamoto S, Tanikawa T, Egawa S, Ichikura H, Abe T, Nakamura M, Kakehi Y, Sugimoto M, Urol Oncol. 2022 Feb;40(2):56.e9-56.e15. doi: 10.1016/j.urolonc.2021.05.003

• 38. Cumulative Incidence and Clinical Risk Factors of Radiation Cystitis after Radiotherapy for Prostate Cancer.

  Makino K, Sato Y, Takenaka R, Yamashita H, Akiyama Y, Yamada Y, Nakamura M, Kawai T, Yamada D, Suzuki M, Kume H. Urol Int. 2022 Mar 15:1-7. doi: 10.1159/000521723. Epub ahead of print. PMID: 35290980.

• 39. Predictive factors for postoperative renal function after off-clamp, non-renorrhaphy partial nephrectomy.

  Nakamura M, Kameyama S, Ambe Y, Teshima T, Izumi T, Tsuru I, Inoue Y, Yoshimatsu T, Inatsu H, Amakawa R, Kusakabe M, Morikawa T, Shiga Y. Transl Androl Urol. 2022 Sep;11(9):1226-1233. doi: 10.21037/tau-22-321.

• 40. Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer.

  Hakozaki Y, Yamada Y, Kawai T, Nakamura M, Takeshima Y, Iwaki T, Teshima T, Kinoshita Y, Fujii Y, Akiyama Y, Sato Y, Yamada D, Suzuki M, Kashiwagi-Hakozaki M, Ushiku T, Kume H. Sci Rep. 2022 Sep 28;12(1):16202. doi: 10.1038/s41598-022-20319-z.

• 41. Preservation of pelvic floor muscles contributes to early continence recovery after robot-assisted radical prostatectomy.

  Nakamura M, Yamada Y, Sato Y, Honda K, Yamada D, Kawai T, Akiyama Y, Suzuki M, Kume H. PLoS One. 2022 Oct 7;17(10):e0275792. doi: 10.1371/journal.pone.0275792. eCollection 2022.

• 42. Evaluation of trends in prescription drugs for overactive bladder in Japanese patients.

  Suzuki M, Yamamoto M, Shiratori T, Naito A, Nakamura M. Int J Urol. 2022 Dec 7. doi: 10.1111/iju.15117

• 43. Low hemoglobin and PSA kinetics are prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients.

  Hakozaki Y, Yamada Y, Takeshima Y, Taguchi S, Kawai T, Nakamura M, Iwaki T, Teshima T, Kinoshita Y, Akiyama Y, Sato Y, Yamada D, Suzuki M, Kume H. Sci Rep. 2023 Feb 15;13(1):2672. doi: 10.1038/s41598-023-29634-5.

• 44. Trends in surgical treatment for prostate cancer: Analysis of National Database Open Data in Japan.

  Nakamura M, Suzuki M, Izumi T, Tsuru I, Muraki Y, Kume H. Glob Health Med. 2023 Feb 28;5(1):62-63. doi; 10.35772/ghm.2022.01065

• 【和文】

• 1. 当院における75歳以上の前立腺癌に対するロボット支援前立腺全摘除後の尿失禁の状況と術後排尿機能に影響を与える因子の検討

  手島太郎, 中村真樹, 佐藤悠介, 川合剛人, 山田大介, 松本明彦, 鈴木基文, 井川靖彦, 久米春喜, 松永明子　日本老年泌尿器科学会誌 32(1): 194-194, 2019.

• 2. 高齢者の泌尿器がん：高齢者腎臓がんの治療前評価や治療上の問題点

  中村真樹, 久米春喜　日本老年泌尿器科学会誌 33(2): 19-24, 2020.

• 3. 男性の排尿姿勢と排尿パラメータとの関係

  鈴木基文, 渡邉大仁, 中村真樹, 佐藤悠佑, 川合剛人, 久米春喜日本老年泌尿器科学会誌 33(1): 115-115, 2020.

• 4. 骨盤底筋訓練（骨盤底筋トレーニング）と多職種連携

  青木芳隆, 大内みふか, 森明子, 若松ひろ子, 佐藤理乃, 中村真樹, 鈴木基文 日本老年泌尿器科学会誌34(2): 24-32, 2021.

• 5. 我が国における骨盤底筋トレーニング導入の歴史

  青木芳隆, 大内みふか, 森明子, 若松ひろ子, 佐藤理乃, 中村真樹, 鈴木基文、日本老年泌尿器科学会誌 35(1): 171-171, 2022.

受賞

• 1. 住友生命社会福祉事業団 海外医学研究助成 2011

• 2. Karolinska Institutets Forskningsstiftelser 2014

• 3. Maud and Birger Stiftelse, 2014-2015

• 4. Postdoktortjänst, Cancerfonden. 2014-2016

学会発表

• 1. 今井俊輔, 中村真樹, 吉松正, 井上泰, 稲津宏紀, 天河亮, 白川昇英, 森川鉄平, 堀内啓, 志賀淑之. 転移性腎細胞癌患者におけるペムブロリズマブとアキシチニブの併用療法中に発現した免疫関連皮膚炎の1例. 於: 第636回日本泌尿器科学会東京地方会; 9.16,2021; Web開催.

• 2. 中村真樹. 鏡視下膀胱全摘除術の術後再発をいかに防ぐか ロボット支援根治的膀胱摘除術後の特殊な再発様式について. 於: 第35回日本泌尿器内視鏡学会総会; 11.12,2021; ハイブリッド開催.

• 3. 骨盤底筋温存がロボット支援根治的前立腺摘除術後の早期尿禁制回復に与える影響、中村真樹、山田雄太、本多一貴、秋山佳之、佐藤悠祐、山田大介、川合剛人、鈴木基文、久米春喜、第31回骨盤外科機能温存研究会、2022.6.11

• 4. シンポジウム「Think different in RARC　予後の改善と合併症の低減」、当院におけるRARC-ICUD　術後早期回復プログラムの導入、中村真樹、第87回日本泌尿器科学会東部総会　2022.10.28

• 5. 術後患者における外来理学療法の可能性　井上泰、津留息吹、泉太郎、天河亮、稲津宏紀、中村真樹、吉松正、志賀淑之、福田明、第74回西日本泌尿器科学会総会　2022.11.4

• 6. ロボット支援根治的膀胱摘除術～術後早期回復プログラムの導入～、中村真樹、泉太郎、津留息吹　天河亮、稲津宏紀、井上泰、志賀淑之、第36回日本泌尿器内視鏡ロボティクス学会　2022.11.12

• 7. Early experience of implementing ERAS protocol during robot-assisted radical prostatectomy　中村真樹　他　第110回日本泌尿器科学会総会　2023.4.24

• 8. Predictive factors for postoperative renal function after off-clamp,non-renorrhaphy partial nephrectomy　中村真樹　他　第110回日本泌尿器科学会総会　2023.4.24

• 9. 前立腺全摘術における出血コントロールの今までとこれから～出血コントロールと機能温存のバランス～　中村真樹　ランチョンセミナー　第110回日本泌尿器科学会総会　2023.4.24

• 10. 未然に防ごう、トラブルシューティング、中村真樹、日本泌尿器内視鏡・ロボティクス学会共催教育セミナー　2023.5.10

• 11. ホルモン療法開始後発熱性好中球減少症を発症した前立腺癌骨髄癌腫症の1例　中村真樹　2023.10.5　日本泌尿器科学会東部総会

• 12. 多職種による術後早期回復部プログラムでおこなうロボット支援膀胱全摘除術の周術期管理　中村真樹　2023.11.9　日本泌尿器内視鏡・ロボティクス学会

• 13. 術後早期回復プログラムで行うRARC周術期管理　中村真樹　2023.11.11　第23回日本クリニカルパス学会

• 他